Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
European Journal of Preventive Cardiology
|
February 21, 2024
Cardiovascular disease as part of Long COVID: a systematic review
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
Journal of Clinical Medicine
|
June 19, 2024
Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults
Marco Bernardi, Luigi Spadafora, Silvia Andaloro, et al.
International Journal of Molecular Sciences
|
February 13, 2025
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?
Salvatore Giordano, Marina Camera, Marta Brambilla, et al.
Panminerva Medica
|
June 19, 2023
Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE International Registry
Luigi Spadafora, Tanya Mohammadi, Marco Bernardi, et al.
Minerva Cardiology and Angiology
|
November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectives
Luigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
Journal of Cardiovascular Pharmacology
|
February 23, 2026
Magnitude of blood pressure reduction in response to levosimendan infusion independently predicts in-hospital mortality in patients with acute heart failure
Gianmarco Sarto, Beatrice Simeone, Francesca Sbandi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents
Luigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.
Journal of the American College of Cardiology
|
September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients
Mattia Galli, Stefano Benenati, Claudio Laudani, et al.
European Journal of Clinical Investigation
|
March 26, 2024
Mitophagy modulation for the treatment of cardiovascular diseases
Maurizio Forte, Luca D'Ambrosio, Gabriele G Schiattarella, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
European Journal of Preventive Cardiology
|
February 21, 2024
Cardiovascular disease as part of Long COVID: a systematic review
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
Journal of Clinical Medicine
|
June 19, 2024
Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults
Marco Bernardi, Luigi Spadafora, Silvia Andaloro, et al.
International Journal of Molecular Sciences
|
February 13, 2025
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?
Salvatore Giordano, Marina Camera, Marta Brambilla, et al.
Panminerva Medica
|
June 19, 2023
Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE International Registry
Luigi Spadafora, Tanya Mohammadi, Marco Bernardi, et al.
Minerva Cardiology and Angiology
|
November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectives
Luigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
Journal of Cardiovascular Pharmacology
|
February 23, 2026
Magnitude of blood pressure reduction in response to levosimendan infusion independently predicts in-hospital mortality in patients with acute heart failure
Gianmarco Sarto, Beatrice Simeone, Francesca Sbandi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents
Luigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.
Journal of the American College of Cardiology
|
September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients
Mattia Galli, Stefano Benenati, Claudio Laudani, et al.
European Journal of Clinical Investigation
|
March 26, 2024
Mitophagy modulation for the treatment of cardiovascular diseases
Maurizio Forte, Luca D'Ambrosio, Gabriele G Schiattarella, et al.
Page
of 9